Yi Wang

机构：Zhejiang Chinese Medical University, Albert Einstein College of Medicine, Hangzhou Normal University, Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, The Fourth People's Hospital, Yebio Bioengineering (China), Zhejiang Taizhou Hospital, Hangzhou Medical College, Taizhou University · ORCID：0000-0001-9048-0092

发表论文 137 篇 · 总被引 3375 次 · h-index 32

代表论文

• Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease (2024 · Nutrition and Diabetes · 被引 25)
• Chemogenomic Screening in a Patient‐Derived 3D Fatty Liver Disease Model Reveals the CHRM1‐TRPM8 Axis as a Novel Module for Targeted Intervention (2024 · Advanced Science · 被引 23)
• Ubiquitin‐specific protease 25 improves myocardial ischemia–reperfusion injury by deubiquitinating NLRP3 and negatively regulating NLRP3 inflammasome activity in cardiomyocytes (2025 · Clinical and Translational Medicine · 被引 16)
• Cardiomyocyte-derived USP13 protects hearts from hypertrophy via deubiquitinating and stabilizing STAT1 in male mice (2025 · Nature Communications · 被引 14)
• USP25 directly interacts with and deubiquitinates PPARα to increase PPARα stability in hepatocytes and attenuate high-fat diet-induced MASLD in mice (2025 · Cell Death and Differentiation · 被引 11)
• Novel application of cyclo(-Phe-Pro) in mitigating aluminum toxicity through oxidative stress alleviation in wheat roots (2024 · Environmental Pollution · 被引 9)